Examkin

Question

Difficulty: HardBias, Confounding, and Validity

Match each epidemiological study scenario with the most accurate methodological or statistical phenomenon it describes.

  • A case-control study assessing oral contraceptive use and venous thromboembolism recruits both cohorts from a tertiary hospital. The exposure independently increases the likelihood of hospital admission for the underlying conditions seen in the control group.Berkson bias
  • A study of a new prostate cancer screening biomarker shows increased 5-year survival in the screened cohort compared to standard care, despite overall disease-specific mortality remaining identical between the two groups.Lead-time bias
  • An observational study notes higher rates of severe infections in patients given a novel biologic versus standard therapy. Chart review indicates the novel drug was primarily prescribed to patients with highly refractory, advanced disease.Confounding by indication
  • A trial of a new statin shows an overall reduction in cardiovascular events. Stratified analysis demonstrates a significant protective effect exclusively in male patients, with no benefit observed in female patients.Effect modification

Answer

Scenario 1 matches with Berkson bias. Scenario 2 matches with Lead-time bias. Scenario 3 matches with Confounding by indication. Scenario 4 matches with Effect modification.
Each scenario precisely describes a unique epidemiological concept. Differential hospital admission rates cause Berkson bias; apparent survival increases without mortality changes indicate lead-time bias; prescribing driven by disease severity creates confounding by indication; and varying intervention efficacy across subgroups defines effect modification.

Step-by-Step Solution

1
Analyze the hospital-based case-control scenario.
The differential admission rates based on exposure status distort the sample.
This is the classic definition of Berkson bias, which requires non-random sampling directly related to hospital admission probabilities.
2
Evaluate the cancer screening scenario with unchanged mortality.
The survival time appears longer only because the disease was diagnosed earlier in its natural history.
When survival time from diagnosis increases but overall mortality does not change, it indicates lead-time bias rather than a true therapeutic benefit.
3
Assess the biologic therapy scenario resulting in severe infections.
The adverse outcome is driven by the baseline severity of the patients' underlying disease, not necessarily the drug itself.
When providers select a specific therapy based on disease severity, and that severity also causes the outcome, it creates confounding by indication.
4
Interpret the statin trial demonstrating different efficacy by sex.
The biological effect of the intervention differs significantly between strata (males vs. females).
When a third variable changes the physiological impact of an intervention, it is effect modification, contrasting with confounding where the third variable merely obscures the true association.

Key Concept

Distinguishing distinct types of epidemiological study distortions and phenomena based on design features and data stratification.
Rate this question

Topics

Bias, Confounding, and Validity

More questions from this topic